1-Tetradecanol, also known as myristyl alcohol, is a straight-chain saturated fatty alcohol. It is a white transparent solid that is virtually insoluble in water. It is soluble in diethyl ether and marginally soluble in ethanol. 1-Tetradecanol can be manufactured by the hydrogenation of myristic acid (or its esters); myristic acid can be found in nutmeg (from where it gains its name). It is also present in coconut oil and palm kernel oil. Majority of 1-tetradecanol is produced from these oils. It may also be produced from petrochemical feedstock via either the Ziegler process or hydroformylation. As with supplementary fatty alcohols, 1-tetradecanol is used as a component in cosmetics such as cold creams for its emollient properties. It is also used as an intermediate in the chemical fusion of other products such as surfactants. Other names of 1-Tetradecanol include n-Tetradecan-1-ol; n-Tetradecanol; n-Tetradecyl alcohol; Alfol 14; Lanette K; Lanette Wax KS; Loxanol V; myristic alcohol; myristyl alcohol; tetradecyl alcohol; n-Tetradecanol-1; 1-Hydroxytetradecane; Dytol R-52; dehydag wax 14; Epal 14; Lanette 14; Lorol C14; Philcohol 1400; Tetradecanol-1; Tetradecan-1-ol; NSC 8549; and Fatty alcohol (C14).
1-Tetradecanol is used as an ingredient in cosmetics such as cold creams. It is an active intermediate in chemical synthesis of sulfated alcohol. It is also employed in the fabrication of temperature-regulated drug release system based on phase-change materials. 1-Tetradecanol plays a vital role in filling the hollow interiors of gold nanocages in the fabrication of new theranostic systems, which possess unique feature of photoacoustic imaging.
Demand for 1-Tetradecanol is anticipated to increase due to the growth in end-user industries such as cosmetics and surfactants. Additionally, rise in consumption of edible oils in emerging economies of Asia Pacific and Latin America is expected to boost the demand for 1-Tetradecanol. However, availability of substitutes and fluctuation in prices of raw materials may hamper market growth.
Asia Pacific is projected to be the major market for 1-Tetradecanol, followed by North America and Europe, in the next few years. China and India are likely to be the prominent consumers of 1-Tetradecanol in Asia Pacific due to presence of established end-user industries in these countries. Republic of Korea, Japan, Vietnam, Malaysia, Cambodia, Australia, New Zealand, and Sri Lanka are estimated to be the other major consumers of 1-Tetradecanol in Asia Pacific. The 1-Tetradecanol market in North America and Europe is anticipated to expand at a moderate pace as compared to that in Asia Pacific due to market saturation.
Large and medium chemical and pharmaceutical manufacturing companies dominate the 1-Tetradecanol market. Key players operating in this market include Guangzhou Sariya Biotech Co., Ltd. (China), Beijing Herbal Health Biotech Ltd (China), Jinan Felicity Biotechnology Co., Ltd.(China), Brenstem Biosciences (India), Capsulution NanoScience AG (Germany), Medtronic (Ireland), GB Biosciences Corporation (U.S.), Leonardo Biosystems Inc (U.S.), RJS Biologics Inc (U.S.), Novosom Verwaltungs GmbH (Germany), and NanoLab Inc (U.S., Triveni Interchem Pvt Ltd.(India), Sigma-Aldrich (U.S.), Alfa Aesar (U.S.), and The Good Scents Company (U.S.).
Companies are adopting aggressive marketing tactics and merger and acquisition strategies to expand their market share. They are also shifting their production facilities to emerging economies of Asia Pacific and Latin America due to the easy availability of land, cheap labor, and governmental subsidies in these regions. Additionally, companies are using export as a tool for geographic expansion in emerging economies of Middle East & Africa.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.